Endometriosis, fibroids and heavy periods: long-term research supports treatment decisions (NIHR, 4 December 2024)

Summary

Treatments for heavy periods, endometriosis and fibroids are available, but women and their clinicians need sufficient information to make shared decisions about care. This NIHR Evidence Collection features long-term research to underpin discussions about these undertreated conditions.

Content

Heavy periods, endometriosis, fibroids, and other women’s health conditions are a huge burden to many. Symptoms can continue for many years, make everyday life a challenge, and have a negative impact on work, school, relationships, social life, self-esteem and emotional wellbeing. Stigma and misinformation mean many women suffer in silence.

Treatments are available, but clinicians and women need sufficient information to make shared decisions about care. High quality evidence comparing the benefits and risks of different treatments, alongside women’s preferences, values and beliefs, can help women receive the care that is right for them.

At the NIHR Evidence webinar (November 2024), researchers presented their findings on the long-term effects of treatments for heavy periods, endometriosis and fibroids. Attendees included clinicians, members of the public, and NHS decision makers, highlighting broad interest in women’s health, and the need for information.

The webinar asked: 

• how do treatments for heavy periods compare after 10 years?
• which hormonal treatment best prevents pain 3 years after endometriosis surgery?
• which fibroid procedure has better outcomes after 4 years?

This Collection summarises the 3 research projects presented at the webinar and includes video clips from the speakers.